NVAX - FDA experts recommend changes to flu shots
2024-03-07 13:29:15 ET
More on AstraZeneca, CSL, etc.
- Sanofi (SNY) TD Cowen 44th Annual Health Care Conference (Transcript)
- GSK Plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy
- CSL Limited: Earnings Beat Doesn't Mask Unfavorable Trial Results (Downgrade)
- GSK’s Blenrep combo therapy meets key goal in multiple myeloma trial
- ViiV’s long-acting HIV therapy outperforms daily therapy in Phase 3 trial